These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 12614743

  • 1. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y.
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [Abstract] [Full Text] [Related]

  • 2. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy.
    Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y.
    Jpn J Ophthalmol; 2002 Mar; 46(5):563-7. PubMed ID: 12457917
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW, Han SH, Son BJ, Rim TH, Keum KC, Yoon JS.
    Graefes Arch Clin Exp Ophthalmol; 2016 May; 254(5):991-8. PubMed ID: 26876240
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.
    Srp Arh Celok Lek; 2000 May; 128(5-6):179-83. PubMed ID: 11089418
    [Abstract] [Full Text] [Related]

  • 5. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone pulse therapy.
    Nagayama Y, Izumi M, Kiriyama T, Yokoyama N, Morita S, Kakezono F, Ohtakara S, Morimoto I, Okamoto S, Nagataki S.
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):513-8. PubMed ID: 3321820
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A, Lastoria S, Ferone D, Pivonello R, Macchia PE, Vassallo P, Bonavolonta G, Muto P, Lombardi G, Fenzi G.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [Abstract] [Full Text] [Related]

  • 8. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
    Koshiyama H, Koh T, Fujiwara K, Hayakawa K, Shimbo S, Misaki T.
    Thyroid; 1994 Nov; 4(4):409-13. PubMed ID: 7711503
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy.
    Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB.
    Ophthalmology; 2001 Sep; 108(9):1523-34. PubMed ID: 11535445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between longitudinal behaviour of some markers of eye autoimmunity and changes in ocular findings in patients with Graves' ophthalmopathy receiving corticosteroid therapy.
    De Bellis A, Bizzarro A, Conte M, Coronella C, Solimeno S, Perrino S, Sansone D, Guaglione M, Wall JR, Bellastella A.
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):388-95. PubMed ID: 12919164
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [Abstract] [Full Text] [Related]

  • 14. Orbital gallium-67 scintigraphy in Graves' ophthalmopathy.
    Konuk O, Atasever T, Unal M, Ayvaz G, Yetkin I, Cakir N, Arslan M, Hasanreisoglu B.
    Thyroid; 2002 Jul; 12(7):603-8. PubMed ID: 12193305
    [Abstract] [Full Text] [Related]

  • 15. Echographic monitoring of response of extraocular muscles to irradiation in Graves' ophthalmopathy.
    Erickson BA, Harris GJ, Lewandowski MF, Murray KJ, Massaro BM.
    Int J Radiat Oncol Biol Phys; 1995 Feb 01; 31(3):651-60. PubMed ID: 7852132
    [Abstract] [Full Text] [Related]

  • 16. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A.
    J Endocrinol Invest; 1991 Nov 01; 14(10):853-60. PubMed ID: 1802923
    [Abstract] [Full Text] [Related]

  • 17. A Prospective, Randomized, Double-blind, Placebo-controlled Study of Orbital Radiotherapy for Graves' Ophthalmopathy.
    Gorman CA, Garrity JA, Fatourechi V, Bahn RS, Petersen IA, Stafford SL, Earle JD, Forbes GS, Kline RW, Bergstralh EJ, Offord KP, Rademacher DM, Stanley NM, Bartley GB.
    Ophthalmology; 2020 Apr 01; 127(4S):S160-S171. PubMed ID: 32200817
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF, Scholz GH.
    Med Klin (Munich); 2004 Feb 15; 99(2):71-6. PubMed ID: 14963657
    [Abstract] [Full Text] [Related]

  • 19. High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy.
    Macchia PE, Bagattini M, Lupoli G, Vitale M, Vitale G, Fenzi G.
    J Endocrinol Invest; 2001 Mar 15; 24(3):152-8. PubMed ID: 11314743
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
    Petersen IA, Kriss JP, McDougall IR, Donaldson SS.
    Int J Radiat Oncol Biol Phys; 1990 Aug 15; 19(2):259-64. PubMed ID: 2118493
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.